You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 11/21/2014

Company Name Symbol %Change
PROGENICS PH PGNX
5.45%
PETROBRAS EG PZE
4.25%
ZEBRA TECH C ZBRA
3.88%
CHINA TELCM- CHA
3.60%
RUBY TUESDAY RT
3.43%
Amdocs Posts Quarterly Revenue Figures

Print Share

Feb 05, 2013 (Close-Up Media via COMTEX) -- Amdocs Limited reported that for its fiscal quarter ended December 31, revenue was $826.4 million, up 0.5 percent sequentially from the fourth fiscal quarter of 2012 and up 2.4 percent as compared to last year's first fiscal quarter.

In a release on January 31, the Company noted that net income on a non-GAAP basis was $119.4 million, or $0.73 per diluted share, compared to non-GAAP net income of $111.3 million, or $0.64 per diluted share, in the first quarter of fiscal 2012. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expenses of $20.4 million, net of related tax effects, in the first quarter of fiscal 2013 and excludes such amortization and other acquisition related costs and equity-based compensation expenses of $18.5 million, net of related tax effects, in the first quarter of fiscal 2012. The Company's GAAP net income for the first quarter of fiscal 2013 was $99.0 million, or $0.61 per diluted share, compared to GAAP net income of $92.7 million, or $0.53 per diluted share, in the prior fiscal year's first quarter.

"We began fiscal 2013 with a record quarter for revenue that was partly driven by a return to year-on-year growth in our North American market. Specifically, we see renewed momentum at AT&T, which is focused on the implementation of its new strategy, including data monetization. In our emerging markets, we delivered 19 percent year-on-year growth in the first quarter and we are on-track to achieve our goal of double-digit growth in this region in fiscal 2013. In Europe, we experienced year-on-year declines owing to difficult macroeconomic conditions and the anticipated ramp down of some transformation projects with certain customers. However, we believe our competitive position in Europe remains strong, and we continue to see opportunities for new business across our portfolio of products and services," said Eli Gelman, chief executive officer of Amdocs Management Limited.

Gelman continued, "Within emerging markets, Latin America remains a critical growth region for Amdocs. Our strategy to focus on securing the large carriers of the region, including America Movil, Telefonica and TIM, is resulting in new customer wins and increased market penetration. We are delighted to announce that Claro Chile, a wholly owned entity of America Movil, has selected Amdocs to consolidate its business and operational support systems (BSS/OSS). Similarly, we recently announced that Amdocs was selected by Telefonica Argentina to implement a transformation program, marking our first project with the Telefonica group in Latin America."

Gelman concluded, "This was another quarter of solid execution that comes on the heels of our strong competitive position and focus. Combined with the strict control of our operating margins, we are comfortable that we can meet our fiscal 2013 guidance and provide an attractive total return to our shareholders."

Financial Discussion of First Fiscal Quarter Results: Free cash flow was $115 million for the quarter, comprised of cash flow from operations of $145 million less $30 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.8 billion at the end of the first quarter of fiscal 2013.

Financial Outlook Amdocs expects that revenue for the second quarter of fiscal 2013 will be approximately $820-$850 million. Diluted earnings per share on a non-GAAP basis for the second fiscal quarter are expected to be $0.69-$0.75, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the second fiscal quarter will be $0.58-$0.66.

Quarterly Cash Dividend Program: On January 30, 2013, the Board approved the next quarterly cash dividend payment and set March 28, 2013 as the record date for determining the shareholders entitled to receive the dividend, which is payable on April 19, 2013.

More information:

www.amdocs.com

((Comments on this story may be sent to newsdesk@closeupmedia.com))

Copyright Close-Up Media, Inc. 2013. All Rights reserved

**********************************************************************

As of Friday, 02-01-2013 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated a DOWNTREND on
05-07-2012 for DOX @ $30.49.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2013 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.